Primary Hepatic Neuroendocrine Carcinomas Treated with a Combination of Cisplatin and Etoposide as First-Line Chemotherapy: Two Case Reports Abstract #597

Introduction: Because primary hepatic neuroendocrine carcinoma (PHNEC) is extremely rare, a standard regimen has not yet been established. However, the combination of etoposide and cisplatin (EP) has been widely used to treat PHNEC.
Aim(s): We report two cases of PHNEC treated with EP and compare the efficacy of the EP regimen for PHNEC and pancreatic NEC (pNEC).
Materials and methods: We retrospectively analyzed the medical records of patients diagnosed with PHNEC and pNEC during January 2007–November 2012.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Medical treatment - Chemotherapy
Presenting Author: Dr. Shoichi Nakazuru

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result